Sovereign Wealth Funds Like Life Extension Tech
Posted on 09/13/2023
Zurich, Switzerland-based Rejuveron Life Sciences AG raised US$ 75 million in a Series B round and convertible loan offering. The funding was co-led by Catalio Capital Management and Apeiron Investment Group, the family office and private investment firm of entrepreneur Christian Angermayer. Catalio Capital Management is the life sciences-focused firm backed by hedge fund billionaires Stan Druckenmiller and Alan Howard.
The company also attracted Abu Dhabi-based Mubadala Capital, a subsidiary of Mubadala Investment Company. Mubadala Capital a prolific biotech investor. Rejuveron revealed it is establishing an office in Abu Dhabi as part of the company’s broader strategy. Rejuveron started collaborations with local universities and hospitals, including NYU Abu Dhabi, to drive research related to aging in the Middle East.
Rejuveron also announced it has acquired a stake in Boost Neuroscience, a brain synapse regeneration company. Boost Neuroscience was founded by Nobel Prize winner Dr Thomas Sudhof, who also serves as a Venture Partner at Catalio.
